BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31647044)

  • 21. Effect of testing methods on incidence of
    McCauley BP; Evans ME; Simbartl LA; Gamage SD; Kralovic SM; Roselle GA
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):461-463. PubMed ID: 33185177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of the Bristol Stool Form Chart scoring system for the laboratory processing of faecal samples in suspected Clostridioides difficile cases.
    Corrigan RA; Sithamparanathan K; Kenny C; Wong THN
    J Hosp Infect; 2020 May; 105(1):95-97. PubMed ID: 31836551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescriber Behavior in Clostridioides difficile Testing: A 3-Hospital Diagnostic Stewardship Intervention.
    Mizusawa M; Small BA; Hsu YJ; Sharara SL; Advic E; Kauffman C; Milstone AM; Feldman L; Pahwa AK; Trivedi JB; Landrum MB; Maragakis LL; Carroll KC; Cosgrove SE; Rock C
    Clin Infect Dis; 2019 Nov; 69(11):2019-2021. PubMed ID: 31125399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Computerized Clinical Decision Support for Diagnostic Stewardship in Clostridioides difficile testing: an Academic Hospital Quasi-Experimental Study.
    Friedland AE; Brown S; Glick DR; Lusby MC; Lemkin D; Leekha S
    J Gen Intern Med; 2019 Jan; 34(1):31-32. PubMed ID: 30218259
    [No Abstract]   [Full Text] [Related]  

  • 25. A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of
    Kraft CS; Parrott JS; Cornish NE; Rubinstein ML; Weissfeld AS; McNult P; Nachamkin I; Humphries RM; Kirn TJ; Dien Bard J; Lutgring JD; Gullett JC; Bittencourt CE; Benson S; Bobenchik AM; Sautter RL; Baselski V; Atlas MC; Marlowe EM; Miller NS; Fischer M; Richter SS; Gilligan P; Snyder JW
    Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of diagnostic and antimicrobial stewardship practices to improve
    Sullivan KV; Gallagher JC; Leekha S; Morgan DJ; Morita K; Rock C; Claeys KC
    Infect Control Hosp Epidemiol; 2022 Jul; 43(7):930-934. PubMed ID: 34376271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the Ultrasensitive Toxin Immunoassay the Solution to the Goldilocks Problem of Clostridioides difficile Diagnostics?
    Kraft C; Mehta N
    Clin Infect Dis; 2022 Jul; 74(12):2150-2151. PubMed ID: 34537826
    [No Abstract]   [Full Text] [Related]  

  • 28. Holding firm: Use of clinical correlation to improve Clostridioides difficile testing.
    Baghdadi J; Ganz DA; Chumpia M; Chang ET; de Peralta SS
    Am J Infect Control; 2020 Sep; 48(9):1104-1107. PubMed ID: 31862165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasensitive Detection of Clostridioides difficile Toxins in Stool by Use of Single-Molecule Counting Technology: Comparison with Detection of Free Toxin by Cell Culture Cytotoxicity Neutralization Assay.
    Hansen G; Young S; Wu AHB; Herding E; Nordberg V; Mills R; Griego-Fullbright C; Wagner A; Ong CM; Lewis S; Yoon J; Estis J; Sandlund J; Friedland E; Carroll KC
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a Clostridioides Difficile Testing Computerized Clinical Decision Support Tool on an Adult Stem Cell Transplantation and Hematologic Malignancies Unit.
    Nix CD; Messer WB; Hale ML; Lewis JS; Strasfeld LM
    Transplant Cell Ther; 2021 Jan; 27(1):94.e1-94.e5. PubMed ID: 33045386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory and Clinical features of EIA Toxin-positive and EIA Toxin-negative Community-acquired Clostridium difficile Infection.
    Patel H; Randhawa J; Nanavati S; Marton LR; Baddoura WJ; DeBari VA
    Ann Clin Lab Sci; 2015; 45(3):333-9. PubMed ID: 26116599
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Righolt CH; Zhang G; Hammond GW; Lagace-Wiens P; Mahmud SM
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1212-1214. PubMed ID: 32624038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilizing a real-time discussion approach to improve the appropriateness of
    Dbeibo L; Brinkman A; Beeler C; Fadel W; Snyderman W; Hatfield N; Sadowski J; Wang Y; Kelley K; Webb D; Azar J; Kara A
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1215-1218. PubMed ID: 32594961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic Stewardship and Inpatient Clostridioides difficile Testing in Solid Organ Transplant Recipients: The Need for Multilevel Checks and Balances.
    Kueht M; Kharsa A; Mujtaba M; Kulkarni R; Britt R; Lea AS; Hafiz G; Fair J; Reynoso D
    Transplant Proc; 2022 Apr; 54(3):605-609. PubMed ID: 35249732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection.
    Baker I; Leeming JP; Reynolds R; Ibrahim I; Darley E
    J Hosp Infect; 2013 Aug; 84(4):311-5. PubMed ID: 23831282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can a toxin gene NAAT be used to predict toxin EIA and the severity of
    Garvey MI; Bradley CW; Wilkinson MAC; Holden E
    Antimicrob Resist Infect Control; 2017; 6():127. PubMed ID: 29270290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of a Computerized Clinical Decision Support Tool on Inappropriate Clostridium difficile Testing.
    White DR; Hamilton KW; Pegues DA; Hanish A; Umscheid CA
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1204-1208. PubMed ID: 28760168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile colitis: an efficient clinical approach to diagnosis.
    Manabe YC; Vinetz JM; Moore RD; Merz C; Charache P; Bartlett JG
    Ann Intern Med; 1995 Dec; 123(11):835-40. PubMed ID: 7486465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.